DURECT Financial Statements
DURECT Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
DURECT Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 30.7 | 21.9 | 28.6 |
| Gross Profit ($ mil.) | 27.5 | 18.6 | 25.7 |
| Operating Income ($ mil.) | (24.5) | (31.4) | (15.6) |
| Total Net Income ($ mil.) | (24.3) | (33.3) | (18.1) |
| Diluted EPS (Net Income) | (0.35) | (0.51) | (0.34) |
DURECT Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 6.3 | 6.4 | 6.6 |
| Gross Profit ($ mil.) | 5.3 | 5.6 | 5.8 |
| Operating Income ($ mil.) | (8.7) | (7.9) | (7.0) |
| Total Net Income ($ mil.) | (8.6) | (7.8) | (7.2) |
| Diluted EPS (Net Income) | (0.11) | (0.11) | (0.10) |
DURECT Stock Quote & Chart
12/02/08 13:53:31 EST •
NASDAQ •
3.43
•
 +0.0300
•
+0.8824 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
DURECT Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 9.72 | 2.00 | 0.83 |
| Price/Earnings Ratio | -- | 9.32 | 9.28 |
| Price/Book Ratio | 6.37 | 1.50 | 0.80 |
| Price/Cash Flow Ratio | -- | 7.89 | 5.25 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed DURECT Financial Ratios
DURECT Competitive Intelligence
| Alpharma | I-Flow | Purdue Pharma | |
|---|---|---|---|
| Annual Sales ($ mil.) | 722.4 | 116.5 | 1,400.0 |
| Employees | 2,000 | -- | 2,200 |
| Market Cap ($ mil.) | 1,401.6 | 96.7 | -- |
Competitive Landscape
